Pradaxa® (dabigatran etexilate) receives final NICE recommendation for stroke prevention in atrial fibrillation in the UK
19 March 2012 | By NICE
Pradaxa® must now be made available for use by the UK National Health Service (NHS)...
List view / Grid view
19 March 2012 | By NICE
Pradaxa® must now be made available for use by the UK National Health Service (NHS)...
20 December 2011 | By Bayer HealthCare
The only new oral anticoagulant approved in three indications across all 27 EU member states...
13 November 2011 | By Pfizer
Bristol-Myers Squibb Company and Pfizer Inc. announced the results of the Phase 3 ADOPT trial...
27 October 2011 | By Boehringer Ingelheim
Update across Europe on Pradaxa®...
11 October 2011 | By kdm communications limited
Frimley Park Hospital in Surrey, UK, has recently invested in Radiometer’s AQT90 FLEX system...
20 May 2011 | By Bristol-Myers Squibb Company
The European Commission has approved ELIQUIS® in the 27 countries of the EU...
10 February 2011 | By Pfizer
Bristol-Myers Squibb Company and Pfizer Inc. announce the publication of their AVERROES study of apixaban in The New England Journal of Medicine...
18 November 2010 | By BUSINESS WIRE
Companies have discontinued the Phase 3 APPRAISE-2 clinical trial in patients...